인공막 탈장수술 기기 시장 보고서 : 탈장 유형, 메쉬, 최종사용자, 지역별(2025-2033년)

The global hernia mesh devices market size reached USD 2.06 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.63 Billion by 2033, exhibiting a growth rate (CAGR) of 2.76% during 2025-2033. The increasing number of hospitals, clinics, and ambulatory surgical centers is stimulating the market.

Hernia mesh is a medical device that helps damaged tissue repair around hernias. It is manufactured from absorbable and non-absorbable materials and relies on stitches, staples, or glue to allow tissues for growing into the device. It is implanted into the upper stomach, groin, or abdomen of the patient undergoing hernia surgery to reduce the rate of recurrence of hernia and strengthen the hernia repair. It also improves patient outcomes by decreasing operative time and minimizing recovery time. As a result, hernia mesh device finds extensive applications in hospitals, clinics, and ambulatory surgical centers.

Hernia Mesh Devices Market Trends:

At present, there is a rise in the prevalence of hernia due to obesity, lifting heavy objects, diarrhea or constipation, persistent coughing, poor nutrition, smoking, and overexertion. This, along with the burgeoning healthcare industry, represents one of the key factors driving the market. Besides this, technological advancements in hernia mesh devices, such as articulating fixation devices and self-fixating meshes, to overcome the problems occurring during laparoscopic processes are contributing to the growth of the market. In addition, articulating fixation devices offer surgeons better access to weak spots within the abdominal wall and enable them to securely place the mesh at the desired body site, which is positively influencing the market. Moreover, various benefits offered by hernia mesh devices, such as resistance to infection and enhanced tensile strength to prevent a recurrence, are propelling the growth of the market. Apart from this, there is an increase in the adoption of robotic surgeries across the globe. This, coupled with the growing demand for advanced meshes among the masses, is offering a positive market outlook. Additionally, the rising demand for robotic hernia surgeries due to lower postoperative pain and enhanced surgeon ergonomics is bolstering the growth of the market.

Key Market Segmentation:

Breakup by Hernia Type:

• Inguinal Hernia
• Incisional Hernia
• Femoral Hernia
• Others

Breakup by Mesh:

• Biologic Mesh
• Synthetic Mesh

Breakup by End User:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG), Becton Dickinson and Company, Cook Group Incorporated, Deep Blue Medical Advances Inc., GEM Srl, Herniamesh S. R. L., Johnson & Johnson, Medtronic plc, Meril Life Sciences Pvt. Ltd., Novus Scientific AB, Samyang Holding Corporation, Stryker Corporation and W. L. Gore & Associates Inc.

Key Questions Answered in This Report

• 1.What was the size of the global hernia mesh devices market in 2024?
• 2.What is the expected growth rate of the global hernia mesh devices market during 2025-2033?
• 3.What are the key factors driving the global hernia mesh devices market?
• 4.What has been the impact of COVID-19 on the global hernia mesh devices market?
• 5.What is the breakup of the global hernia mesh devices market based on the hernia type?
• 6.What is the breakup of the global hernia mesh devices market based on the mesh?
• 7.What is the breakup of the global hernia mesh devices market based on the end user?
• 8.What are the key regions in the global hernia mesh devices market?
• 9.Who are the key players/companies in the global hernia mesh devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Hernia Mesh Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Hernia Type

• 6.1 Inguinal Hernia
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Incisional Hernia
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Femoral Hernia
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Mesh

• 7.1 Biologic Mesh
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Synthetic Mesh
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Clinics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Ambulatory Surgical Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG)
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 SWOT Analysis
  • 14.3.2 Becton Dickinson and Company
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Cook Group Incorporated
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Deep Blue Medical Advances Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 GEM Srl
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Herniamesh S. R. L.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Johnson & Johnson
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Medtronic plc
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Meril Life Sciences Pvt. Ltd.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Novus Scientific AB
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Samyang Holding Corporation
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
  • 14.3.12 Stryker Corporation
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis
  • 14.3.13 W. L. Gore & Associates Inc.
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
    • 14.3.13.3 SWOT Analysis